Two Asian pharmas hold key for global supply of Oxford vaccine

Two Asian pharmas hold key for global supply of Oxford vaccine

  • India’s Serum aims for 400m doses in 2020; S Korea’s SK Bioscience keen on exports

MUMBAI/SEOUL — Two Asian pharmaceutical companies are poised to become key players in the global fight against the new coronavirus pandemic after they were tapped to help mass-produce a promising new vaccine for the disease, which has already killed 650,000 worldwide and infected over 16 million.